Board of Directors

Shlomo Ben-Haim, MD, D.Sc – Co-Founder and Chairman

Dr. Ben-Haim is the co-founder of a number of successful medical and biomedical companies in the fields of congestive heart failure, obesity, diabetes, esthetics and cosmetics, anti-viral medications, deep vein thrombosis prevention, therapy for limb ischemia and post-stroke and sports-injury rehabilitation. His formal education is in the fields of nuclear physics, mathematics, biomedical engineering, philosophy and medicine. He has held faculty appointments as a Professor of Medicine, Physiology and Biophysics, at Harvard University and the Technion – Israel Institute of Technology. Dr. Ben-Haim has published over 200 scientific papers in peer-reviewed journals and holds over 380 patents and patent applications.

Prof. Harold Lebovitz, MD, FACE– Director

Dr. Lebovitz has previously served as Chief of the Section of Endocrinology and Diabetes, and Director of the National Institutes of Health (NIH)-sponsored Clinical Research Center at the State University of New York Health Science Center, where he currently serves as a Professor. He also currently serves on the Board of Directors of the American Association of Clinical Endocrinologists (AACE). He is an internationally recognized authority in the field of diabetes and is author or co-author of more than 200 peer-reviewed publications and 100 chapters or books. Dr. Lebovitz received his BSc and MD from the University of Pittsburgh.

Dr. Simos Kedikoglou, MD, CFA, MBA – Director

Dr. Simos Kedikoglou is the President of the MedInvest group. He was previously a Corporate Vice President of Business Development for Boston Scientific with responsibility for acquisitions, licensing and distribution deals in the US, Europe and Asia. Prior to Boston Scientific, Simos was an Associate Partner with McKinsey & Company in the US, focusing on M&A and has advised clients in completed healthcare deals with a combined value of $45 billion. Simos holds a Medical Degree from the University of Athens, Greece, an MBA with distinction and a Master’s in Public Health from Harvard University, and he is a CFA Charterholder.

James Keyes – Director

James Keyes is a Bermuda resident and citizen.  He was a partner for Appleby, the offshore law firm, for eleven years until he retired from the firm in 2008. He joined Appleby in 1993 and was team leader of the Funds & Investment Services Team.  Prior to Appleby, he was employed in the Corporate Department of Freshfields law firm, and worked in London, New York and Hong Kong offices.  Mr. Keyes attended Oxford University in England as a Rhodes Scholar and graduated with a degree in Politics, Philosophy and Economics (M.A. with Honours) in 1985.  He was admitted as a non-executive director of a number of funds and companies.  He is also managing director of Renaissance Capital, the emerging markets investment group.  He became a Notary Public in 1988.